Follow
Laavanya Sankaranarayanan
Laavanya Sankaranarayanan
Verified email at duke.edu
Title
Cited by
Cited by
Year
Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
JD Grevet, X Lan, N Hamagami, CR Edwards, L Sankaranarayanan, X Ji, ...
Science 361 (6399), 285-290, 2018
1422018
A hyperactive transcriptional state marks genome reactivation at the mitosis–G1 transition
CCS Hsiung, CR Bartman, P Huang, P Ginart, AJ Stonestrom, CA Keller, ...
Genes & development 30 (12), 1423-1439, 2016
1092016
Exploiting genetic variation to uncover rules of transcription factor binding and chromatin accessibility
V Behera, P Evans, CJ Face, N Hamagami, L Sankaranarayanan, ...
Nature Communications 9 (1), 782, 2018
402018
Isoniazid and rifampicin as therapeutic regimen in the current era: a review
S Somasundaram, A Ram, L Sankaranarayanan
Journal of Tuberculosis Research 2014, 2014
362014
FRI455 Polycystic Ovary Syndrome-Associated DENND1A Non-Coding Risk Loci Alter Gene Expression
L Sankaranarayanan, G Johnson, A Barrera, AE Dunaif, T Reddy
Journal of the Endocrine Society 7 (Supplement_1), bvad114. 1642, 2023
2023
Glucocorticoid Receptor Regulated KCNA5 Mediates Cell Proliferation in Human Fetal Membranes
SJ Cunningham, A Barrera, L Sankaranarayanan, TK Allen, TE Reddy
2022
Domain-Focused CRISPR-Cas9 Screen Identifies Hri Kinase As a Regulator of Fetal Hemoglobin in Adult Human Erythroid Cells
JD Grevet, N Hamagami, X Lan, L Sankaranarayanan, S Bhardwaj, ...
Blood 130, 536, 2017
2017
Deep Mining of Natural Genetic Variation in Erythroid Cells Reveals New Insights about In Vivo Transcription Factor Binding and Chromatin Accessibility
V Behera, P Evans, CJ Face, L Sankaranarayanan, GA Blobel
Blood 128 (22), 3879, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–8